Yuri B. Porozov

Olympic Ave 1
Sochi, KDA 354340, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Late-phase strategies to overcome limitations of PD-1/PD-L1 therapy: a clinical development trajectory through 2030.

Late-phase strategies to overcome limitations of PD-1/PD-L1 therapy: a clinical development trajectory through 2030.

Journal: Frontiers in oncology

Published: May 08, 2026

Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats.

Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats.

Journal: Frontiers in immunology

Published: October 21, 2025

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Journal: Biochemical pharmacology

Published: September 13, 2025

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Journal: Biochemical pharmacology

Published: September 13, 2025

Application of Rational Design and Molecular Metadynamics for the Estimation of Changes in Trans-Splicing Efficiency during the Mutagenesis of Ssp DnaE Intein.

Application of Rational Design and Molecular Metadynamics for the Estimation of Changes in Trans-Splicing Efficiency during the Mutagenesis of Ssp DnaE Intein.

Journal: ACS bio & med chem Au

Published: April 03, 2025

3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM.

3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 21, 2025

New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis.

New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis.

Journal: Pharmaceutics

Published: February 21, 2025

You Win Some, You Lose Some: Modifying the Molecular Periphery of Nitrofuran-Tagged Diazaspirooctane Reshapes Its Antibacterial Activity Profile.

You Win Some, You Lose Some: Modifying the Molecular Periphery of Nitrofuran-Tagged Diazaspirooctane Reshapes Its Antibacterial Activity Profile.

Journal: International journal of molecular sciences

Published: November 28, 2024

Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10.

Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10.

Journal: International journal of molecular sciences

Published: August 06, 2024

Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity.

Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity.

Journal: Molecules (Basel, Switzerland)

Published: May 24, 2024

Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators-Inhibitors of Bacterial Cystathionine γ-Lyase.

Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators-Inhibitors of Bacterial Cystathionine γ-Lyase.

Journal: International journal of molecular sciences

Published: October 17, 2023

Novel 1,2,4-Triazole- and Tetrazole-Containing 4H-Thiopyrano[2,3-b]quinolines: Synthesis Based on the Thio-Michael/aza-Morita-Baylis-Hillman Tandem Reaction and Investigation of Antiviral Activity.

Novel 1,2,4-Triazole- and Tetrazole-Containing 4H-Thiopyrano[2,3-b]quinolines: Synthesis Based on the Thio-Michael/aza-Morita-Baylis-Hillman Tandem Reaction and Investigation of Antiviral Activity.

Journal: Molecules (Basel, Switzerland)

Published: September 09, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026